CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Capponi Vincent President and COO | Other acquisition · Series B Right Warrants | +31,760 | 31,760 | ||
| 2025-01-17 | Deliargyris Efthymios Chief Medical Officer | Option exercise | +16,233 | $1.00 | $16K | 403,025 |
| 2025-01-17 | Deliargyris Efthymios Chief Medical Officer | Option exercise · Subscription Rights (right to buy) | −16,233 | 0 | ||
| 2025-01-17 | Deliargyris Efthymios Chief Medical Officer | Other acquisition · Series A Right Warrants | +16,233 | 16,233 | ||
| 2025-01-17 | Deliargyris Efthymios Chief Medical Officer | Other acquisition · Series B Right Warrants | +16,233 | 16,233 | ||
| 2025-01-17 | Sobel Alan D. Director | Option exercise | +21,950 | $1.00 | $22K | 123,807 |
| 2025-01-17 | Sobel Alan D. Director | Option exercise · Subscription Rights (right to buy) | −21,950 | 0 | ||
| 2025-01-17 | Sobel Alan D. Director | Other acquisition · Series A Right Warrants | +21,950 | 21,950 | ||
| 2025-01-17 | Sobel Alan D. Director | Other acquisition · Series B Right Warrants | +21,950 | 21,950 | ||
| 2025-01-17 | Chan Phillip P. Chief Executive Officer | Option exercise | +90,832 | $1.00 | $91K | 1,243,195 |
| 2025-01-17 | Chan Phillip P. Chief Executive Officer | Option exercise · Subscription Rights (right to buy) | −90,832 | 0 | ||
| 2025-01-17 | Chan Phillip P. Chief Executive Officer | Other acquisition · Series A Right Warrants | +90,832 | 90,832 | ||
| 2025-01-17 | Chan Phillip P. Chief Executive Officer | Other acquisition · Series B Right Warrants | +90,832 | 90,832 | ||
| 2025-01-17 | MARIANI PETER J Chief Financial Officer | Option exercise | +32,625 | $1.00 | $33K | 433,988 |
| 2025-01-17 | MARIANI PETER J Chief Financial Officer | Option exercise · Subscription Rights (right to buy) | −32,625 | 0 | ||
| 2025-01-17 | MARIANI PETER J Chief Financial Officer | Other acquisition · Series A Right Warrants | +32,625 | 32,625 | ||
| 2025-01-17 | MARIANI PETER J Chief Financial Officer | Other acquisition · Series B Right Warrants | +32,625 | 32,625 | ||
| 2024-12-13 | MARIANI PETER J Chief Financial Officer | Purchase | +20,000 | $0.96 | $19K | 401,363 |
| 2024-12-12 | MARIANI PETER J Chief Financial Officer | Purchase | +20,000 | $0.89 | $18K | 381,363 |
| 2024-12-11 | MARIANI PETER J Chief Financial Officer | Purchase | +11,363 | $0.89 | $10K | 361,363 |
Page 3 of 35 · 698 trades